|
|
CDC NIP/NIC Home Page
|
Count Basie B
| |||
B2: Meningoccocal Conjugate Vaccine and Guillain-Barre Syndrome | |||
| Presenters in this workshop will discuss the investigation of possible GBS following receipt of meningococcal conjugate vaccine (MCV4) and will describe a decision analysis for use of MCV4 given the risk of GBS. | |||
| Moderator: | Robert Davis | ||
| 2:00 PM | Introductory Remarks | ||
| 2:05 PM | 7 | Guillain-Barré Syndrome following receipt of Meningococcal Conjugate Vaccine Claudia Vellozzi, Scott R. Campbell, Eric Weintraub, Nancy Rosenstein | |
| 2:25 PM | 8 | Routine MCV Vaccination in the Presence of Vaccine-Associated Guillain-Barré Syndrome - Decision Analysis Approach Bo-Hyun Cho, Thomas Clark, Nancy Rosenstein Messonnier, Mark Messonnier | |
| 2:45 PM | Discussion | ||